Case File №
#VI-2026-0223
Laicuinuo LCN
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
33 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Tirzepatide | B Good | 7 | 8.0 | 5.2 | 10.0 | 30 Sep 2025 |
| 5-amino-1MQ | X N/A | 1 | 10.0 | 10.0 | 10.0 | 11 Jun 2025 |
| AHK-CU | X N/A | 1 | 6.7 | 6.7 | 6.7 | 2 Jul 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 7.2 | 7.2 | 7.2 | 6 May 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 10.0 | 10.0 | 10.0 | 14 Jan 2025 |
| Cardiogen | X N/A | 1 | 6.4 | 6.4 | 6.4 | 20 Jun 2025 |
| Cartalax | X N/A | 1 | 8.6 | 8.6 | 8.6 | 21 May 2025 |
| Cerebrolysin | X N/A | 1 | 8.5 | 8.5 | 8.5 | 28 Mar 2025 |
| Chonluten | X N/A | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 |
| DHB (1-Test Cyp) Oral | X N/A | 1 | 7.8 | 7.8 | 7.8 | 6 May 2025 |
| DHB (1-Test Cyp) | X N/A | 1 | 9.2 | 9.2 | 9.2 | 20 Jun 2025 |
| Dianabol Raw | X N/A | 1 | 8.5 | 8.5 | 8.5 | 25 Apr 2025 |
| DSIP | X N/A | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 |
| EPO | X N/A | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 6.8 | 6.8 | 6.8 | 3 Jul 2025 |
| Glutathione | X N/A | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 |
| GW-501516 (Cardarine) | X N/A | 1 | 8.9 | 8.9 | 8.9 | 3 Jul 2025 |
| HGH Fragment 176-191 | X N/A | 1 | 6.3 | 6.3 | 6.3 | 21 May 2025 |
| IGF-1 LR3 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 14 Jan 2025 |
| KissPeptin-10 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 27 Feb 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 5.6 | 5.6 | 5.6 | 25 Apr 2025 |
| LGD-4033 (Ligandrol) | X N/A | 1 | 9.0 | 9.0 | 9.0 | 2 Apr 2025 |
| LL37 | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 |
| Methylene Blue | X N/A | 1 | 6.3 | 6.3 | 6.3 | 13 Feb 2025 |
| MOTS-C | X N/A | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 |
| MT-1 | X N/A | 1 | 8.4 | 8.4 | 8.4 | 2 Jul 2025 |
| NAD+ Injectable | X N/A | 1 | 6.1 | 6.1 | 6.1 | 25 Apr 2025 |
| Orforglipron | X N/A | 1 | 9.1 | 9.1 | 9.1 | 11 Jun 2025 |
| Prostamax | X N/A | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 8.6 | 8.6 | 8.6 | 8 Jul 2025 |
| Semaglutide Raw | X N/A | 1 | 8.2 | 8.2 | 8.2 | 24 Apr 2025 |
| T3 (Liothyronine) | X N/A | 1 | 8.2 | 8.2 | 8.2 | 8 Jul 2025 |
| Thymalin | X N/A | 1 | 6.0 | 6.0 | 6.0 | 3 Jul 2025 |
Exhibit II
Evidence Log
39 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Glutathione | 9.2 A | 50mg | 46.2mg | -7.6% | 97.84% | 9flroy | Lab E | Public |
| 24 May 2026 | 5-amino-1MQ | 10.0 A | 30mg | 26.7mg | -10.9% | 98.21% | episl9 | Lab D | Public |
| 24 May 2026 | Prostamax | 7.9 A | 10mg | 10.4mg | +3.9% | 97.76% | 51imqi | Lab F | Community |
| 24 May 2026 | Thymalin | 5.6 B | 30mg | 35.1mg | +17.1% | 95.45% | qs3cr2 | Lab A | Public |
| 23 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.1 A | 10mg | 9.7mg | -3.2% | 97.54% | ipgrue | Lab E | Public |
| 23 May 2026 | Methylene Blue | 6.8 A | 100mg | 110.9mg | +10.9% | 99.53% | 2gox2m | Lab C | Public |
| 23 May 2026 | DSIP | 9.7 A | 2mg | 2.4mg | +20.6% | 98.83% | 1h5rh1 | Lab G | Community |
| 21 May 2026 | EPO | 6.9 A | 15mg | 15.5mg | +3.2% | 96.39% | 75j6lq | Lab D | Public |
| 21 May 2026 | LGD-4033 (Ligandrol) | 9.4 A | 50mg | 57.6mg | +15.2% | 97.66% | gfrm6w | Lab B | Public |
| 20 May 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 9.7 A | 20mg | 23.1mg | +15.4% | 99.81% | mxilb6 | Lab F | Public |
| 17 May 2026 | MOTS-C | 9.6 A | 20mg | 22.1mg | +10.7% | 97.78% | 7f0e7h | Lab D | Public |
| 17 May 2026 | NAD+ Injectable | 6.5 A | 100mg/ml | 108.8mg/ml | +8.8% | 99.13% | t3srkv | Lab D | Community |
| 29 Jan 2026 | DHB (1-Test Cyp) | 9.3 A | 100mg/ml | 108.1mg/ml | +8.1% | 96.68% | yfa03n | Lab C | Community |
| 26 Jan 2026 | Selank 10mg + Semax 10mg Blend | 8.6 A | 10mg | 9.0mg | -10.3% | 95.34% | htq336 | Lab G | Community |
| 26 Jan 2026 | Semaglutide Raw | 9.3 A | 500g | 453.5g | -9.3% | 99.54% | geojus | Lab A | Public |
| 19 Jan 2026 | Cerebrolysin | 10.0 A | 10mg | 12.0mg | +19.8% | 95.26% | 4xh9ld | Lab A | Public |
| 9 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.3 A | 100g | 101.9g | +1.9% | 98.02% | y5xgax | Lab A | Public |
| 9 Jan 2026 | HGH Fragment 176-191 | 7.2 A | 10mg | 11.6mg | +15.5% | 98.50% | pof9av | Lab E | Public |
| 7 Jan 2026 | Tirzepatide | 8.4 A | 20mg | (no batch claim) | 21.7mg | +8.5% | 99.70% | White Label / Silver Crimp / Violet Cap | Lab G |
| 7 Jan 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.5 A | 20mg | 24.8mg | +23.8% | 97.13% | 1eaytw | Lab E | Community |
| 6 Jan 2026 | Dianabol Raw | 9.9 A | 100g | 91.1g | -8.9% | 95.11% | 720haj | Lab A | Public |
| 6 Jan 2026 | T3 (Liothyronine) | 10.0 A | 50mg | 49.4mg | -1.1% | 97.41% | 93p9h4 | Lab B | Community |
| 29 Dec 2025 | Cartalax | 8.9 A | 2mg | 2.1mg | +5.3% | 96.78% | ew44m2 | Lab G | Community |
| 12 Dec 2025 | AHK-CU | 8.1 A | 30mg | 37.5mg | +25.0% | 97.19% | hi19pg | Lab G | Community |
| 6 Dec 2025 | Tirzepatide | 6.3 B | 20mg | (no batch claim) | 34.6mg | +73.0% | 99.95% | White Label / Silver Crimp / Violet Cap | Lab E |
| 5 Dec 2025 | Cardiogen | 7.5 A | 5mg | 5.5mg | +9.9% | 95.94% | sclt27 | Lab D | Community |
| 5 Dec 2025 | IGF-1 LR3 | 6.0 A | 15mg | 16.9mg | +12.9% | 95.71% | 9eimlf | Lab F | Community |
| 5 Dec 2025 | LL37 | 5.0 B | 30mg | 28.1mg | -6.4% | 98.55% | 1yxis7 | Lab G | Community |
| 17 Nov 2025 | GW-501516 (Cardarine) | 10.0 A | 20mg | 19.2mg | -4.0% | 98.44% | c3d4rz | Lab A | Community |
| 14 Nov 2025 | Orforglipron | 9.0 A | 25mg | 30.4mg | +21.8% | 98.02% | ult60a | Lab B | Community |
| 5 Nov 2025 | DHB (1-Test Cyp) Oral | 7.8 A | 20mg | 18.3mg | -8.3% | 96.03% | iuipuo | Lab B | Public |
| 4 Nov 2025 | Chonluten | 9.9 A | 30mg | 31.4mg | +4.7% | 96.42% | qg8kee | Lab G | Public |
| 4 Nov 2025 | KissPeptin-10 | 6.9 A | 2mg | 1.8mg | -10.1% | 97.92% | gm2kok | Lab A | Community |
| 24 Oct 2025 | Tirzepatide | 7.1 A | 30mg | (no batch claim) | 32.09mg | +7.0% | 99.80% | No Label / Silver Crimp / Pink Cap | Lab G |
| 24 Oct 2025 | Tirzepatide | 5.2 C | 5mg | 6.4mg | 4.98mg | -22.1% | 99.60% | (no data) | Lab G |
| 23 Oct 2025 | Tirzepatide | 10.0 A | 30mg | (no batch claim) | 30.6mg | +2.0% | 99.95% | No Label / Silver Crimp / Pink Cap | Lab E |
| 9 Oct 2025 | MT-1 | 9.7 A | 30mg | 26.7mg | -10.9% | 98.55% | gqc4hu | Lab A | Public |
| 3 Oct 2025 | Tirzepatide | 9.8 A | 10mg | (no batch claim) | 10mg | 99.82% | White Label / Silver Crimp / Yellow Cap | Lab E | |
| 30 Sep 2025 | Tirzepatide | 9.5 A | 30mg | 30.6mgpackage | 29.8mg | -2.7% | 99.93% | No Label / Silver Crimp / Violet Cap | Lab E |
— END OF EVIDENCE LOG —